Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fibrinogen concentrate for postpartum haemorrhage
ACTRN12614000691640Phase 3Not yet recruiting
- Sponsor
- Auckland City Hospital
- Start
- Dec 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postpartum hemorrhage (PPH) comparing Fibrinogen concentrate with Placebo saline (2 arms). Primary endpoint: Primary efficacy endpoint. Planned start Dec 2014; status: not yet recruiting.
02
Drugs
Fibrinogen human
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on ACTRN12614000691640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000691640.